US 10975153
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10975153 (Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)) held by Five Prime Therapeutics, Inc. expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P19/02